X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 12/07/2024 17:05

Study reveals potential cognitive benefits of antidiabetic drugs

Investigators analyzing the potential cognitive effects of antidiabetic medications in records of more than 1.5 million patients with type 2 diabetes mellitus (T2DM) found risks of dementia and Alzheimer's disease (AD) were significantly lower in patients treated with metformin and sodium glucose co-transporter-2 inhibitors (SGLT-2i) compared to other antidiabetic drugs.

Articles similaires

Sorry! Image not available at this time

Risk for Foot Disease Modestly Lower With SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists in T2DM

drugs.com - 06/Jan 15:01

TUESDAY, Jan. 6, 2026 -- For adults with type 2 diabetes mellitus (T2DM), new users of sodium-glucose cotransporter 2 inhibitors (SGLT-2is) have a...

Incretin-based diabetes drugs show potential protective effects against dementia

news.medical.net - 03:58

A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated...

Incretin-based diabetes drugs show potential protective effects against dementia

news.medical.net - 03:58

A large McGill University study has found that two classes of medications commonly prescribed for Type 2 diabetes, both incretin-based, are associated...

This diabetes drug may reduce foot nerve damage

knowridge.com - 06/Jan 11:08

A new study from Denmark suggests that one type of diabetes drug may help protect people with type 2 diabetes from developing foot problems. The study...

This diabetes drug may reduce foot nerve damage

knowridge.com - 06/Jan 11:08

A new study from Denmark suggests that one type of diabetes drug may help protect people with type 2 diabetes from developing foot problems. The study...

1 in 4 older people with dementia take risky brain drugs despite warnings

knowridge.com - 13/Jan 11:30

Even though doctors have been warned for years not to use certain brain-affecting medications in people with dementia, a new study shows that one in...

1 in 4 older people with dementia take risky brain drugs despite warnings

knowridge.com - 13/Jan 11:30

Even though doctors have been warned for years not to use certain brain-affecting medications in people with dementia, a new study shows that one in...

Most patients regain lost weight within two years of stopping obesity drugs

news.medical.net - 13/Jan 14:24

Weight management medications show limited long-term effects, with rapid weight regain post-treatment, emphasizing the need for sustainable obesity...

Sorry! Image not available at this time

A hydration guide for people on GLP-1s

wn.com - 14/Jan 03:25

Mumumutelu // Shutterstock Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are used to treat obesity, Type 2 diabetes, and more. These...

Sorry! Image not available at this time

A hydration guide for people on GLP-1s

wn.com - 14/Jan 03:25

Mumumutelu // Shutterstock Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are used to treat obesity, Type 2 diabetes, and more. These...